Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

As California ends Medicaid coverage for GLP-1 weight loss drugs like Wegovy and Zepbound, experts say the state's advice to ...

By Maggie Fick, Mrinalika Roy and Sabrina ValleSAN FRANCISCO, Jan 12 (Reuters) - Oral weight-loss drugs could account for a ...

Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...

Bariatric surgery and GLP-1 drugs are associated with reductions in fat mass and a shift in body composition toward a higher ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

In a Monday interview with CNBC's Jim Cramer, Novo Nordisk CEO Mike Doustdar suggested the new pill format of the ...

Novo Nordisk anticipates oral weight-loss drugs will capture one-third or more of the GLP-1 market by 2030, driven by ...

"I have become indifferent to food. I still love it. I still love it. But I'm not in any way obsessed about it," Oprah ...

Nick Reiner's weight gain set him on a murderous path, but it didn't have to be that way ... just ask Dr. Drew.

Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like ...